Literature DB >> 25293722

Detection and measurement of surface contamination by multiple antineoplastic drugs using multiplex bead assay.

Jerome P Smith1, Deborah L Sammons2, Shirley A Robertson2, Jack R Pretty2, D Gayle DeBord2, Thomas H Connor2, John E Snawder2.   

Abstract

OBJECTIVES: Contamination of workplace surfaces by antineoplastic drugs presents an exposure risk for healthcare workers. Traditional instrumental methods to detect contamination such as liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) are sensitive and accurate but expensive. Since immunochemical methods may be cheaper and faster than instrumental methods, we wanted to explore their use for routine drug residue detection for preventing worker exposure.
METHODS: In this study we examined the feasibility of using fluorescence covalent microbead immunosorbent assay (FCMIA) for simultaneous detection and semi-quantitative measurement of three antineoplastic drugs (5-fluorouracil, paclitaxel, and doxorubicin). The concentration ranges for the assay were 0-1000 ng/ml for 5-fluorouracil, 0-100 ng/ml for paclitaxel, and 0-2 ng/ml for doxorubicin. The surface sampling technique involved wiping a loaded surface with a swab wetted with wash buffer, extracting the swab in storage/blocking buffer, and measuring drugs in the extract using FCMIA.
RESULTS: There was no significant cross-reactivity between these drugs at the ranges studied indicated by a lack of response in the assay to cross analytes. The limit of detection (LOD) for 5-fluorouracil on the surface studied was 0.93 ng/cm(2) with a limit of quantitation (LOQ) of 2.8 ng/cm(2), the LOD for paclitaxel was 0.57 ng/cm(2) with an LOQ of 2.06 ng/cm(2), and the LOD for doxorubicin was 0.0036 ng/cm(2) with an LOQ of 0.013 ng/cm(2).
CONCLUSION: The use of FCMIA with a simple sampling technique has potential for low cost simultaneous detection and semi-quantitative measurement of surface contamination from multiple antineoplastic drugs.
© The Author(s) 2014.

Entities:  

Keywords:  Antineoplastic drugs (5-fluorouracil; doxorubicin); multiplex measurement; paclitaxel; surface analysis

Mesh:

Substances:

Year:  2014        PMID: 25293722      PMCID: PMC4567514          DOI: 10.1177/1078155214554407

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN: 1078-1552            Impact factor:   1.809


  11 in total

1.  Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides.

Authors:  Raymond E Biagini; Sonela A Schlottmann; Deborah L Sammons; Jerome P Smith; John C Snawder; Cynthia A F Striley; Barbara A MacKenzie; David N Weissman
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

2.  Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers.

Authors:  Thomas H Connor; D Gayle DeBord; Jack R Pretty; Marc S Oliver; Tracy S Roth; Peter S J Lees; Edward F Krieg; Bonnie Rogers; Carmen P Escalante; Christine A Toennis; John C Clark; Belinda C Johnson; Melissa A McDiarmid
Journal:  J Occup Environ Med       Date:  2010-10       Impact factor: 2.162

3.  Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease.

Authors:  Mark Bower; Ophelia Veraitch; Richard Szydlo; Peter Charles; Peter Kelleher; Brian Gazzard; Mark Nelson; Justin Stebbing
Journal:  Blood       Date:  2009-02-17       Impact factor: 22.113

4.  Multiplexed analysis of human cytokines by use of the FlowMetrix system.

Authors:  K G Oliver; J R Kettman; R J Fulton
Journal:  Clin Chem       Date:  1998-09       Impact factor: 8.327

5.  Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.

Authors:  Paul J M Sessink; Thomas H Connor; James A Jorgenson; Timothy G Tyler
Journal:  J Oncol Pharm Pract       Date:  2010-02-15       Impact factor: 1.809

6.  Advanced multiplexed analysis with the FlowMetrix system.

Authors:  R J Fulton; R L McDade; P L Smith; L J Kienker; J R Kettman
Journal:  Clin Chem       Date:  1997-09       Impact factor: 8.327

7.  Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities.

Authors:  Wouter Fransman; Roel Vermeulen; Hans Kromhout
Journal:  Int Arch Occup Environ Health       Date:  2005-05-11       Impact factor: 3.015

8.  Measurement of multiple drugs in urine, water, and on surfaces using fluorescence covalent microbead immunosorbent assay.

Authors:  Jerome Smith; Deborah Sammons; Shirley Robertson; Raymond Biagini; John Snawder
Journal:  Toxicol Mech Methods       Date:  2010-10-13       Impact factor: 2.987

9.  Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system.

Authors:  Chun-Yip Hon; Kay Teschke; Paul A Demers; Scott Venners
Journal:  Ann Occup Hyg       Date:  2014-03-18

10.  Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak.

Authors:  Christine C Ginocchio; Frank Zhang; Ryhana Manji; Suman Arora; Mark Bornfreund; Leon Falk; Madhavi Lotlikar; Margaret Kowerska; George Becker; Diamanto Korologos; Marcella de Geronimo; James M Crawford
Journal:  J Clin Virol       Date:  2009-06-16       Impact factor: 3.168

View more
  2 in total

1.  New approaches to wipe sampling methods for antineoplastic and other hazardous drugs in healthcare settings.

Authors:  Thomas H Connor; Jerome P Smith
Journal:  Pharm Technol Hosp Pharm       Date:  2016-07-27

Review 2.  Cytostatics in Indoor Environment: An Update of Analytical Methods.

Authors:  M Francisca Portilha-Cunha; A Alves; Mónica S F Santos
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.